Article
Advances in Single-Cell Sequencing Technology and its Applications in Triple-Negative Breast Cancer
2021-11-10
Abstract excerpt
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and is mainly treated with chemotherapy-based combination therapy. In recent years, the increasing development of single-cell sequencing (SCS) has become one of the most promising technologies in the field of biotechnology. The study of the heterogeneity of TNBC tumor cells using SCS will expand our current knowledge of metastasis...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 107684db-7fab-5a07-b138-cd974552b63a
- DOI
- 10.21203/rs.3.rs-1034157/v1
